Review: orlistat and sibutramine are modestly effective for weight loss at 1 year.
University of Southampton and Southamptom University Hospitals Trust, Southampton, England, UK.ACP journal club 01/2005; 142(1):19. DOI: 10.1136/ebm.10.1.13
[Show abstract] [Hide abstract]
ABSTRACT: Obesity is a leading cause of preventable mortality worldwide, with current strategies for treatment including life-style changes, pharmacological intervention and bariatric surgery. With pharmacological intervention showing at best modest patient benefits, new treatments are required. Modulation of anorectic gut hormones could offer the potential to elicit the required life-changing level of efficacy only currently seen with bariatric surgery, and without the cardiovascular risk associated with a number of the current marketed therapies. This review will discuss the gut hormones glucagon-like peptide-1 (GLP-1), Ghrelin and cholecystokinin (CCK) - more advanced non-peptide chemical matter has been discovered acting through these hormone pathways and/or their receptors.Drug discovery today 11/2013; 19(7). DOI:10.1016/j.drudis.2013.10.025 · 5.96 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.